Found: 6
Select item for more details and to access through your institution.
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2009, v. 2, p. 21
- By:
- Publication type:
- Article
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 622, doi. 10.1007/s10637-022-01235-5
- By:
- Publication type:
- Article
Phase II Study of Topotecan and Bevacizumab in Advanced, Refractory Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 5, p. 495, doi. 10.1016/j.cllc.2013.04.009
- By:
- Publication type:
- Article
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited Tissue.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 10, p. 499
- By:
- Publication type:
- Article
Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2499, doi. 10.3390/cancers14102499
- By:
- Publication type:
- Article
The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5206, doi. 10.3390/cancers13205206
- By:
- Publication type:
- Article